DMR Logo.png
Personalized Medicine Biomarker Market Size to Reach USD 72.7 Billion By 2033, at 17.5 CAGR: Insights by Dimension Market Research
01 juil. 2024 11h34 HE | Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Personalized Medicine Biomarker Market size is expected to reach USD 17.0 billion by 2024 and it is further anticipated to reach...
KFSHRC_2
KFSHRC Performs Over 5,000 Successful Kidney Transplants
01 juil. 2024 03h57 HE | King Faisal Specialist Hospital & Research Centre
KFSHRC Performs Over 5,000 Successful Kidney Transplants
KFSHRC_2
KFSH&RC Leads Global Healthcare Revolution with AI and Robotics King Faisal Specialist Hospital & Research Centre (KFSH&RC) Leads the Global Healthcare Revolution with AI and Robotics
image (5).png
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
25 juin 2024 09h00 HE | Qure.ai Technologies Limited
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI.
Acino and Allecra Therapeutics
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
24 juin 2024 03h00 HE | Acino International AG
Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...
Spherix Global Insig
Spherix Global Insights Appoints Leigh Anne Siino as Chief Revenue Officer
17 juin 2024 15h43 HE | Spherix Global Insights
EXTON, PA, June 17, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
ADALVO LIMITED
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
13 juin 2024 06h38 HE | ADALVO LIMITED
Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.
cmi_logo.png
[Latest] Global Protein Purification and Isolation Market Size/Share Worth USD 22,003.8 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
10 juin 2024 09h00 HE | Custom Market Insights
Austin, TX, USA, June 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Protein Purification and Isolation Market Size, Trends and Insights By Product...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
06 juin 2024 09h00 HE | Sermonix Pharmaceuticals Inc.
IND approval in China allows Shanghai Henlius Biotech, Sermonix’s Chinese development partner for oral lasofoxifene, to enroll ELAINE-3 trial patients in ChinaUnder strategic collaboration agreement...
23andMe_Logo_grey.png
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
03 juin 2024 08h00 HE | 23andMe, Inc.
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and...